
News
All series
All News


Valeant Pharmaceuticals has entered into an agreement to acquire B+L for $8.7 billion, which includes $4.2 billion in debt. The deal is expected to close in Q3, and B+L will retain its name.

B+L subsidiary Ista pleads guilty to conspiracy charges in anti-kickback case and agrees to pay $34M in civil and criminal fines.

Study shows that patients wearing 1-Day Acuvue TruEye lenses exhibit no clinically significant differences as compared to spectacle wearers after a year of lens wear.

Study shows retinal imaging technology better detects retinal lesions compared with ophthalmoscopy.

Industry supports EyeXam mobile app to help users find local eyecare practitioners.

Senju acquired the rights to co-develop and market Allegro's integrin peptide therapy for intravitreal injection for vascular eye diseases such as AMD and diabetic macular edema.







Dr. Ernie Bowling shares how Lou Catania’s final lecture before retirement spurs a memory of a great teacher.

Two new studies add to the growing evidence that time spent outdoors helps reduce the risk of myopia in children.

Optometry Giving Sight announces its Philanthropist of the Year, Practice of the Year, and World Sight Day Challenge Outstanding Contribution.

The American Optometric Association joins the American Society of Cataract and Refractive Surgery in tackling integrated eye care and patient delivery.






New treatments for age-related macular degeneration may be on the horizon because researchers are now able to develop pluripotent stem cells faster and easier.

Cloud-based turnkey software solution Echo from Eyemaginations allows healthcare professionals to communicate with patients from any Internet-based device.

The toric intraocular lens (IOL) provides a greater range, enhanced efficacy, more precise visual recovery for the cataract patient, and reduced potential of complications in a single surgery. Also, toric lenses provide the opportunity for optometrists to co-manage the patient’s recovery.

QLT entered into an agreement with Mati in December and closed the deal in April.

Vision loss caused by AMD may be prevented with cholesterol-lowering drugs.

The 2013 editorial Webinar series kicks off with a discussion lens care prescribing.

MaximEyes customers will soon experience revenue cycle management enhancements.

